Heather D. Turner

Insider Reports History

Location
San Diego, CA
Signature
/s/ David Strauss, as Attorney-in-Fact for Heather D Turner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Heather D. Turner:

Form 4 holding Chief Executive Officer, Director

LB PHARMACEUTICALS INC

Security class
Employee Stock Option (Right to Buy)
Shares / value
971,828
Estimated value
Report date
10 Sep 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief General Counsel

Lyell Immunopharma, Inc.

Security class
Option (right to buy)
Shares / value
300,000
Estimated value
Report date
16 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Avalyn Pharma Inc.

Security class
Stock Option (Right to Buy)
Shares / value
26,978
Estimated value
Report date
29 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Heather D. Turner

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .